Expression Proteomics Predicts Loss of RXR-γ during Progression of Epithelial Ovarian Cancer

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kalra, Rajkumar S ^a   Bapat, Sharmila A ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; ADAPALENE; ALITRETINOIN; RETINOID X RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEOMICS; SENSITIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; MALE; MICE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTEOMICS; RETINOID X RECEPTOR GAMMA; RETINOIDS; SIGNAL TRANSDUCTION;

EID: 84881125188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070398     Document Type: Article

References (32)

1. Xie BX, Zhang H, Wang J, Pang B, Wu RQ, et al. (2011) Analysis of differentially expressed genes in LNCaP prostate cancer progression model. J Androl 32: 170-182.
2. Dumont N, Crawford YG, Sigaroudinia M, Nagrani SS, Wilson MB, et al. (2009) Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy. Breast Can Res 11: R87.
3. Hruban RH, Wilentz RE, Kern SE, (2000) Genetic progression in the pancreatic ducts. Am J Pathol 156: 1821-1825.
4. Hanahan D, Weinberg RA, (2000) The hallmark of cancers. Cell 100: 57-70.
5. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
6. Am Can So, Inc. (2012) Society American Cancer: Cancer facts and figures 2012.
7. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J. Clin 60: 277-300.
8. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, et al. (2010) Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29: 1103-1113.
9. Bell DA, (2005) Origins and molecular pathology of ovarian cancer. Mod Pathol 18: S19-S32.
10. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, et al. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Gen Dev 15: 50-65.
11. Kislinger T, Cox B, Kannan A, Chung C, Hu P, et al. (2006) Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 125: 173-86.
12. Hanash SM, Pitteri SJ, Faca VM, (2008) Mining the plasma proteome for cancer biomarkers. Nat 452: 571-9.
13. Kulasingam V, Diamandis EP, (2008) Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract 5: 588-99.
14. Bapat SA, Mali AM, Koppikar CB, Kurrey NK, (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Can Res 65: 3025-9.
15. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira YLR, (2000) Cellular retinol-binding protein expression and breast cancer. J Natl Can Inst 92: 475-480.
16. Roberts D, Williams SJ, Cvetkovic D, Weinstein JK, Godwin AK, et al. (2002) Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. DNA Cell Biol 21: 11-19.
17. Cvetkovic D, Williams SJ, Hamilton TC, (2003) Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer. Clin Can Res 9: 1013-1020.
18. Wani AA, Sharma N, Shouche YS, Bapat SA, (2006) Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 25: 6336-6344.
19. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, et al. (2009) Snail and Slug mediate radio- and chemo-resistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059-2068.
20. Sharma N, Jadhav SP, Bapat SA, (2010) CREBBP re-arrangements affect protein function and lead to aberrant neuronal differentiation. Differentiation 79: 218-31.
21. Auersperg N, Maines-Bandiera SL, Dyck HG, (1997) Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol 173: 261-265.
22. Mangelsdorf DJ, Evans RM, (1995) The RXR heterodimers and orphan receptors. Cell 83: 841-850.
23. Konopleva M, Elstner E, McQueen TJ, Tsao T, Sudarikov A, et al. (2004) Peroxisome proliferator-activated receptor and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Can Therap 3: 1249-1262.
24. de Lera AR, Bourguet W, Altucci L, Gronemeyer H, (2007) Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nat Rev Drug Discov 6: 811-820.
25. Fulda S, Debatin KM, (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-811.
26. Auersperg N, (2010) The Origin of Ovarian Carcinomas: A Unifying Hypothesis. Int J of Gynec Path 30: 12-21.
27. Simoneau AR, Jones PA, (1994) Bladder cancer: the molecular progression to invasive disease. World J Urol 12: 89-95.
28. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, et al. (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Can Res 56: 2488.
29. Garnis C, Buys TP, Lam WL, (2004) Genetic alteration and gene expression modulation during cancer progression. Mol Can 3: 9.
30. Gudas LJ, Wagner JA, (2011) Retinoids regulate stem cell differentiation. J Cell Physiol 226: 322-330.
31. Brabender J, Metzger R, Salonga D, Danenberg KD, Danenberg PV, et al. (2005) Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis 26: 525-530.
32. Lee SM, Lee JY, Choi JE, Lee SY, Park JY, et al. (2010) Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features. Can Gen Cytogenet 197: 39-45.